한글목차

에피제네틱 시장 동향 및 전망

세계 에피제네틱 시장은 2023년부터 2028년까지 14.5%의 CAGR로 2028년까지 약 36억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 투자, 자금 조달 및 승인 증가로 인한 에피제네틱 연구 및 개발 노력 강화, 신약 개발 촉진에 대한 에피제네틱의 적용 확대, 저렴한 가격과 접근성으로 인한 게놈 시퀀스에 대한 접근성 확대입니다. 세계 에피제네틱 시장의 미래는 학계, 연구기관, 제약회사, 생명공학 기업, 임상시험수탁기관(CRO)의 비지니스 기회로 인해 유망한 것으로 평가됩니다.

에피제네틱 시장의 인사이트

• Lucintel은 사용하기 쉽고 비용 효율적이며 고급 에피제네틱 키트 및 시약에 대한 수요가 전 세계적으로 증가함에 따라 키트 및 시약이 예측 기간 동안 가장 큰 부문이 될 것으로 예상하고 있습니다.
• 이 시장 내에서 정부 연구 기관과 대학 연구소에서 에피제네틱 제품을 광범위하게 채택함에 따라 학술 및 연구 기관이 가장 큰 최종 사용 부문으로 남을 것입니다.
• 북미는 첨단 의료 인프라에 대한 인식이 높아지고, R&D 비용이 증가하며, 이 지역의 주요 기업이 존재하기 때문에 예측 기간 동안 가장 큰 지역으로 남을 것입니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다:

• Q1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q2. 어떤 부문이 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
• Q3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q4. 시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장의 주요 과제와 비지니스 리스크는 무엇인가?
• Q5. 이 시장에서의 비지니스 리스크와 경쟁 위협은 무엇인가?
• Q6. 이 시장의 새로운 트렌드와 그 이유는?
• Q7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 에피제네틱 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2017년부터 2028년까지 시장 동향과 예측 분석

• 거시경제 동향(2017-2022년)과 예측(2023-2028년)
• 세계의 에피제네틱 시장 동향(2017-2022)과 예측(2023-2028)
• 제품 및 서비스별 세계 에피제네틱 시장
  • 키트와 시약
  • 효소
  • 기기와 부속품
  • 소프트웨어
  • 서비스
• 기술별 세계의 에피제네틱 시장
  • DNA 메틸화
  • 히스톤 메틸화
  • 기타
• 최종 이용 산업별 세계 에피제네틱 시장
  • 학술조사기관
  • 제약회사와 바이오테크놀러지 기업
  • 수탁조사기관(CRO)
  • 기타

제4장 2017년부터 2028년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 에피제네틱 시장
• 북미의 에피제네틱 시장
• 유럽의 에피제네틱 시장
• 아시아태평양 에피제네틱 시장
• 기타 지역 에피제네틱 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 제품 및 서비스별 세계 에피제네틱 시장 성장 기회
  • 기술별 세계의 에피제네틱 시장 성장 기회
  • 최종 이용 산업별 세계 에피제네틱 시장 성장 기회
  • 지역별 세계의 에피제네틱 시장 성장 기회
• 세계의 에피제네틱 시장의 최신 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 에피제네틱 시장 능력 확대
  • 세계의 에피제네틱 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Abcam
• Active Motiff
• Hologic
• F. Hoffmann-La Roche
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Novartis
• Element Biosciences
• Dovetail Genomics

영문목차

Epigenetic Market Trends and Forecast

The future of the global epigenetic market looks promising with opportunities in the academic and research institutes, pharmaceutical companies and biotechnology companies, and contract research organizations (CROs). The global epigenetic market is expected to reach an estimated $3.6 billion by 2028 with a CAGR of 14.5% from 2023 to 2028. The major drivers for this market are enhanced commitment to epigenetic research and development through increased investment, funding, and approvals, growing application of epigenetics in advancing drug discovery and development, and broadening access to genome sequencing owing to its affordability and accessibility.

A more than 150-page report is developed to help in your business decisions.

Epigenetic Market by Segment

The study includes trends and forecast for the global epigenetic market by product & service, technology, end use industry, and region as follows:

Epigenetic Market by Product & Service [Shipment Analysis by Value from 2017 to 2028]:

• Kits & Reagents
• Enzymes
• Instruments & Accessories
• Software
• Services

Epigenetic Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

• DNA Methylation
• Histone Methylation
• Others

Epigenetic Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

• Academic and Research Institutes
• Pharmaceutical Companies and Biotechnology Companies
• Contract Research Organizations (CROs)
• Others

Epigenetic Market by Region [Shipment Analysis by Value from 2017 to 2028]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Epigenetic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, epigenetic companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the epigenetic companies profiled in this report include:

• Abcam
• Active Motiff
• Hologic
• F. Hoffmann-La Roche
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Novartis
• Element Biosciences
• Dovetail Genomics

Epigenetic Market Insights

• Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period due to growing demand for simple-to-use, cost-effective, and advanced epigenetic kits and reagents across the globe.
• Within this market, academics and research institutes will remain the largest end use segment due to the widespread adoption of epigenetic products across government research institutions and university laboratories.
• North America will remain the largest region over the forecast period due to increasing awareness of advanced medical infrastructure, growing R&D expenditures, and the existence of major companies in this region.

Features of the Global Epigenetic Market

• Market Size Estimates: Epigenetic market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
• Segmentation Analysis: Epigenetic market size by various segments, such as by product & service, technology, end use industry, and region in terms of value ($B).
• Regional Analysis: Epigenetic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different products & services, technologies, end use industries, and regions for the epigenetic market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the Epigenetic Market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

• Q.1. What is the epigenetic market size?
• Answer: The global epigenetic market is expected to reach an estimated $3.6 billion by 2028.
• Q.2. What is the growth forecast for epigenetic market?
• Answer: The global epigenetic market is expected to grow with a CAGR of 14.5% from 2023 to 2028
• Q.3. What are the major drivers influencing the growth of the epigenetic market?
• Answer: The major drivers for this market are enhanced commitment to epigenetic research and development through increased investment, funding, and approvals, growing application of epigenetics in advancing drug discovery and development, and broadening access to genome sequencing owing to its affordability and accessibility.
• Q4. What are the major segments for epigenetic market?
• Answer: The future of the global epigenetic market looks promising with opportunities in academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs).
• Q5. Who are the key epigenetic companies?
• Answer: Some of the key epigenetic companies are as follows:
  • Abcam
  • Active Motiff
  • Hologic
  • F. Hoffmann-La Roche
  • Illumina
  • Qiagen
  • Thermo Fisher Scientific
  • Novartis
  • Element Biosciences
  • Dovetail Genomics
• Q6. Which epigenetic market segment will be the largest in future?
• Answer: Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period due to growing demand for simple-to-use, cost-effective, and advanced epigenetic kits and reagents across the globe.
• Q7. In epigenetic market, which region is expected to be the largest in next 5 years?
• Answer: North America will remain the largest region over the forecast period due to increasing awareness of advanced medical infrastructure, growing R&D expenditures and the existence of major companies in this region.
• Q.8. Do we receive customization in this report?
• Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the global epigenetic market by product & service (kits & reagents, enzymes, instruments & accessories, software, and services), technology (DNA methylation, histone methylation, and others), end use industry (academic and research institutes, pharmaceutical companies and biotechnology companies, contract research organizations (CROs), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Epigenetic Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

• 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
• 3.2: Global Epigenetic Market Trends (2017-2022) and Forecast (2023-2028)
• 3.3: Global Epigenetic Market by Product & Service
  • 3.3.1: Kits & Reagents
  • 3.3.2: Enzymes
  • 3.3.3: Instruments & Accessories
  • 3.3.4: Software
  • 3.3.5: Services
• 3.4: Global Epigenetic Market by Technology
  • 3.4.1: DNA Methylation
  • 3.4.2: Histone Methylation
  • 3.4.3: Others
• 3.5: Global Epigenetic Market by End Use Industry
  • 3.5.1: Academic and Research Institutes
  • 3.5.2: Pharmaceutical Companies and Biotechnology Companies
  • 3.5.3: Contract Research Organizations (CROs)
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

• 4.1: Global Epigenetic Market by Region
• 4.2: North American Epigenetic Market
  • 4.2.1: North American Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.2.2: North American Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others
• 4.3: European Epigenetic Market
  • 4.3.1: European Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.3.2: European Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others
• 4.4: APAC Epigenetic Market
  • 4.4.1: APAC Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.4.2: APAC Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others
• 4.5: ROW Epigenetic Market
  • 4.5.1: ROW Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.5.2: ROW Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Epigenetic Market by Product & Service
  • 6.1.2: Growth Opportunities for the Global Epigenetic Market by Technology
  • 6.1.3: Growth Opportunities for the Global Epigenetic Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Epigenetic Market by Region
• 6.2: Emerging Trends in the Global Epigenetic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Epigenetic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Epigenetic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abcam
• 7.2: Active Motiff
• 7.3: Hologic
• 7.4: F. Hoffmann-La Roche
• 7.5: Illumina
• 7.6: Qiagen
• 7.7: Thermo Fisher Scientific
• 7.8: Novartis
• 7.9: Element Biosciences
• 7.10: Dovetail Genomics